These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16644664)

  • 1. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: The Valpolicella Heart Diabetes Study.
    Targher G; Bertolini L; Tessari R; Zenari L; Arcaro G
    Diabetes Care; 2006 May; 29(5):1178. PubMed ID: 16644664
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et al.
    Targher G; Bertolini L; Zoppini G; Lippi G; Zenari L
    Diabetes Care; 2007 Jun; 30(6):e51; author reply e52. PubMed ID: 17526813
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
    Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
    Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus.
    Gimeno-Orna JA; Faure-Nogueras E; Castro-Alonso FJ; Boned-Juliani B
    Am J Cardiol; 2009 May; 103(10):1364-7. PubMed ID: 19427429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study.
    Targher G; Bertolini L; Tessari R; Zenari L; Arcaro G
    Diabet Med; 2006 Nov; 23(11):1270-1. PubMed ID: 17054609
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
    Jeganathan VS; Cheung N; Wong Y
    Diabet Med; 2008 Jul; 25(7):882; author reply 882-3. PubMed ID: 18513307
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.
    van Hecke MV; Dekker JM; Stehouwer CD; Polak BC; Fuller JH; Sjolie AK; Kofinis A; Rottiers R; Porta M; Chaturvedi N;
    Diabetes Care; 2005 Jun; 28(6):1383-9. PubMed ID: 15920056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Organ complications in patients with diabetes mellitus type 2 diagnosed during hospitalization due to other diseases in the year 2004].
    Radziszewski AS; Ostrega-Dudek B; Suseł A; Kopeć P; Radziszewski AB
    Przegl Lek; 2006; 63 Suppl 7():56-8. PubMed ID: 17784545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
    Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: a 10-year observation study.
    Lövestam-Adrian M; Hansson-Lundblad C; Torffvit O
    Diabetes Res Clin Pract; 2007 Jul; 77(1):141-7. PubMed ID: 17178168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
    Azadbakht L; Atabak S; Esmaillzadeh A
    Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications.
    Gaede PH
    Dan Med Bull; 2006 Aug; 53(3):258-84. PubMed ID: 17092449
    [No Abstract]   [Full Text] [Related]  

  • 18. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.
    Groop PH; Thomas MC; Rosengård-Bärlund M; Mills V; Rönnback M; Thomas S; Forsblom C; Taskinen MR; Viberti G
    Diabetes Care; 2007 Oct; 30(10):2706-7. PubMed ID: 17620444
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.